Last Updated on March 5, 2025 by The Health Master
Spurious Drugs
The Drug Testing Laboratory (DTL) recently uncovered a shocking reality: seven pharma companies are manufacturing and distributing spurious drugs in the Pakistani drug market.
These “spurious” drugs pose a grave threat to public health, potentially containing toxic substances.
Spurious Drugs: A Dangerous Threat
The DTL, in a report signed by Sindh Director Syed Adnan Rizvi, revealed that these companies are operating under false pretenses.
Fake Licenses and Addresses: The report highlights the alarming discovery that the license numbers printed on these medications were never issued, and the addresses listed on the packaging are completely fabricated.
Absence of Active Ingredients: These spurious drugs had no Active Pharmaceutical Ingredients (APIs). APIs are the main components in the drugs that provide therapeutic effects.
The absence of the APIs in the drugs is potentially harmful and ineffective.
List of Spurious Drugs:
The DTL identified dangerous spurious drugs, including:
Antibiotics:
- Eyosef 250 mg capsules (East Pharmaceuticals, Lahore) are used to treat bacterial infections.
Anti-infective Suspensions:
- Alcoxime suspension (Alpine Laboratories (Pvt) Ltd, Karachi)
- Milixime suspension (Menakline Pharma, Karachi)
- Mirzpan suspension (Miraz Pharma, Kasur)
Antianxiety Medications:
- Mirzolam tablets (Miraz Pharma, Kasur)
- Lexopam tablets (Porm Pharmaceuticals, Peshawar)
- Zionex tablet (Multicare Pharmaceutical Karachi)
- Bromalex (Brom Pharmaceuticals Lahore)
Potential Health Risks
The consequences of consuming these spurious drugs can be risky for the health:
Toxic Substances: These drugs may contain harmful toxins and even narcotics in lethal doses.
Unhygienic conditions: These drugs may be manufactured in unhygienic conditions, which may pose a potential risk to the health, e.g., infection, contamination.
Ineffective treatment: The absence of the active pharmaceutical ingredients in these drugs may lead to ineffective treatment, which may pose health risks.
“These medications were being sold in the market, but the license numbers of these products were never allotted.
Even addresses of the pharmaceutical companies mentioned on the drugs were fake,” stated Noor Mahar, President of the Pakistan Drug Lawyers Forum, in an interview with Dawn.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Pakistan: Drug Production Quality Under Scrutiny, Concerns Raised in Senate Committee
Pakistan: Pharma Company Faces Imprisonment and Fines for NSQ Drug
Pakistan in Healthcare Crisis: Struggle to Afford Life-Saving Medicines
Drug recall: Glenmark and FDC recall Drugs due to this issue
Online Registration of Cosmetics in India: CDSCO
Key Notes on Revised Schedule M: Metered Dose Inhalers
Surprise Inspection of Pharma Companies by Rajasthan
USFDA inspection at Zydus API plant with zero observations
Opportunity to Supply APIs to Venezuela: Pharmexcil
Digital program for Pharmacists launched
NPPA revised ceiling price of 2 formulations: February 2025
Extension of the deadline for Revised Schedule M: Final notification
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
